Nov 14 (Reuters) - Acerus Pharmaceuticals Corporation ASP.TO :
* ACERUS REPORTS THIRD QUARTER AND YEAR-TO-DATE FISCAL 2019 FINANCIAL RESULTS
* ACERUS PHARMACEUTICALS QTRLY TOTAL REVENUE WAS NEGATIVE $0.2 MILLION COMPARED TO $1.6 MILLION IN THE THIRD QUARTER OF 2018
* ACERUS PHARMACEUTICALS QTRLY NET LOSS PER SHARE OF $0.02
* ACERUS PHARMACEUTICALS - CASH AS OF SEPT 30, WAS $4.1 MILLION COMPARED WITH $3.8 MILLION ON DECEMBER 31, 2018